Alembic Pharmaceuticals has reported results for third quarter ended December 31, 2016.
The company has reported 50.58% fall in its net profit at Rs 137.83 crore for the quarter under review as compared to Rs 278.92 crore for the same quarter in the previous year. Total income of the company decreased by 11.51% at Rs 804.99 crore for the quarter under review as compared Rs 909.65 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported 67.81% fall in its net profit after taxes, Minority Interest and Share of Profit / (Loss) of Associates at Rs 86.55 crore for the quarter ended December 31, 2016 as compared to Rs 268.87 crore for the same quarter in the previous year. Total Income of the company decreased by 16.76% to Rs 777.19 crore for quarter under review from Rs 933.69 crore for the quarter ended December 31, 2015.
